Cell and gene therapy clinical trial starts vs Sales growth at constant exchange rates

Cell and gene therapy clinical trial starts and Sales growth at constant exchange rates worldwide, compared over time.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Cell and gene therapy clinical trial starts

Unit: count · 2 observations

Line chart
Cell and gene therapy clinical trial startsCell and gene therapy clinical trial starts. 2 observations from 2019–2023 to 2023, ranging from 631 to 3,285. Latest value 631 (2023). 0 1,000 2,000 3,000 4,000 2019 2020 2021 2022 2023 2024 2025 2026 3,285 631
Cell and gene therapy clinical trial startsCell and gene therapy clinical trial starts. 2 observations from 2019–2023 to 2023, ranging from 631 to 3,285. Latest value 631 (2023). 0 1,000 2,000 3,000 4,000 2019 2020 2021 2022 2023 2024 2025 2026 3,285 631
Cell and gene therapy clinical trial startsCell and gene therapy clinical trial starts. 2 observations from 2019–2023 to 2023, ranging from 631 to 3,285. Latest value 631 (2023). 0 1,000 2,000 3,000 4,000 2019 2020 2021 2022 2023 2024 2025 2026 3,285 631
View the underlying data
Cell and gene therapy clinical trial starts
Period Type Value
2019–2023 Actual 3,285
2023 Actual 631
Source: IQVIA · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2019 2020 2021 2022 2023 2024 2025 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2019 2020 2021 2022 2023 2024 2025 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2019 2020 2021 2022 2023 2024 2025 2026 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Cell and gene therapy clinical trial starts

Number of clinical trials of cell and gene therapies started in a given period.

2 observations in Global · source organisations: IQVIA

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related